NAUT - NASDAQ
Nautilus Biotechnology, Inc.
$2.71
+0.93%Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
At a Glance
Live SnapshotNo Revenue Data
NAUT has not reported any revenue values in the available annual periods.
Nautilus Biotechnology, Inc. Profit Bridge
Profitability Analysis
Nautilus Biotechnology, Inc. Income Statement
NAUT • NASDAQ
| Nautilus Biotechnology, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||
GROSS PROFIT | ||||||||
(6.5M) | (6.4M) | (5.7M) | (3.4M) | (2.8M) | (2.3M) | (0.0) | (0.0) | |
-6.5M | -6.4M | -5.7M | -3.4M | -2.8M | -2.3M | 0.0 | 0.0 | |
OPERATING INCOME | ||||||||
(60.4M) | (75.1M) | (70.4M) | (60.2M) | (47.7M) | (13.4M) | (9.6K) | (111.7M) | |
(25.7M) | (31M) | (28.9M) | (23.7M) | (21.1M) | (3.3M) | (1.6K) | (111.7M) | |
(41.1M) | (50.5M) | (47.3M) | (36.5M) | (26.5M) | (10.1M) | (8.5K) | (0.0) | |
-66.8M | -81.5M | -76.2M | -63.6M | -50.5M | -15.7M | -10.1K | -111.7M | |
PRE-TAX INCOME | ||||||||
(0.0) | (0.0) | (0.0) | (5.8M) | (0.0) | (0.0) | (0.0) | (0.0) | |
7.9M | 10.8M | 12.6M | 0.0 | 329K | 0.0 | 0.0 | 0.0 | |
-6.5M | -6.4M | -5.7M | (0.0) | (0.0) | (0.0) | -492.0 | (0.0) | |
7.8M | 10.7M | 12.5M | 5.7M | 183K | 125K | -9.6M | 738.3M | |
-59M | -70.8M | -63.7M | -57.9M | -50.3M | -15.6M | -9.6M | 626.6M | |
NET INCOME | ||||||||
-59M | -70.8M | -63.7M | -57.9M | -50.3M | -15.6M | -9.6K | 626.6M |
SEC Filings
NAUT - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | April 28, 2026 | April 28, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | June 17, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | April 28, 2026 | March 31, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 26, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 04, 2025 | November 03, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | October 28, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 28, 2025 | October 28, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | July 31, 2025 | June 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | July 31, 2025 | July 31, 2025 | 2025 |
Related Guides
Continue your NAUT research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.